Get startedLog in
    Picture of Apogee Therapeutics logo

    APGE — Apogee Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapMomentum Trap
    All News

    Brief: Apogee Therapeutics - Enters Il-31R License Agreement With Paragon On June 17, 2026 - SEC Filing

    Picture of Apogee Therapeutics logoApogee Therapeutics
    22/06/2026 12:53
    BRIEF-Apogee Therapeutics - Enters Il-31R License Agreement With Paragon On June 17, 2026 - SEC Filing
    June 22 (Reuters) - Apogee Therapeutics Inc APGE.O:
    • APOGEE THERAPEUTICS - ENTERS IL-31R LICENSE AGREEMENT WITH PARAGON ON JUNE 17, 2026 - SEC FILING
    • APOGEE THERAPEUTICS - TO PAY PARAGON UP TO $23.25 MILLION FOR MILESTONES UNDER IL-31R LICENSE AGREEMENT - SEC FILING
    • APOGEE THERAPEUTICS - ENTERS ANTIBODY DISCOVERY AGREEMENT WITH PARAGON THERAPEUTICS ON JUNE 17, 2026 - SEC FILING
    • APOGEE THERAPEUTICS - TO PAY PARAGON $1.3 MILLION-$2 MILLION FOR CMC ACTIVITIES - SEC FILING
    Source text: [ID:n0001140361-26-025841]
    Further company coverage: APGE.O

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Apogee Therapeutics

    See all news